Alembic Pharmaceuticals gains USFDA final approval for Carbamazepine Extended-Release Tablets
Carbamazepine Extended-Release Tablets are indicated for use as an anticonvulsant drug and also for treating pain associated with…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Alembic Pharmaceuticals
Alembic Pharmaceuticals receives USFDA EIR for API-III facility in Gujarat
The inspection at the Karakhadi-based manufacturing site was conducted by the USFDA from 17 to 21 March 2025
Alembic gains USFDA final approval for Amlodipine & Atorvastatin Tablets USP, 2.5 mg/10 mg, 2.5…
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Caduet Tablets, of Pharmacia and…
Alembic Pharmaceuticals receives US FDA EIR for Panelav oncology facility
US FDA inspection for injectable and oral solid formulation unit conducted in October 2024 has been successfully closed
Alembic Pharmaceuticals secures US FDA approval for Pantoprazole Sodium Injection
Regulatory clearance enables Alembic to launch generic equivalent of Protonix I.V. in the US market
Dr Archana Hingorani completes tenure as Independent Director at Alembic Pharmaceuticals
Dr Archana Hingorani ceases to be a Director at Alembic Pharmaceuticals following the completion of her second consecutive…
Indian pharma companies focus on innovative research in foreign countries through dedicated entities
According to GlobalData’s Pharmaceutical Intelligence Center, as of 20 December 2024, there are a total of 16 drugs in the…
Alembic Pharmaceuticals receive USFDA approval for Divalproex Sodium capsules
Approval marks Alembic’s 193rd final ANDA approval in the United States market
Alembic Pharma gets form 483 with five procedural observations by USFDA
The GMP inspection was conducted at the company’s Jarod facility
Alembic gains Guinness World Record for hypertension awareness milestone
On World Hypertension Day the team launched a week-long campaign that reached out to 15,568 Healthcare Professionals (HCPs)